Novel approach for identification of left ventricle geometry in patients with chronic heart failure, AH and IHD in combination with COPD.


  • V. A. Potabashniy



chronic heart failure, arterial hypertension, ischemic heart disease, chronic obstructive pulmonary disease, geometry of left ventricle


The aim of this study was to examine the direction of change of left ventricle (LV) geometry in patients with chronic heart failure (CHF), arterial hypertension (AH) and ischemic heart disease (IHD) in combination with chronic obstructive pulmonary disease (COPD) in dependence on severity of clinical signs of CHF and COPD based on recommendation of American Society of Echocardiography and European Association of Cardiovascular Images (2015). We examined 67 patients with CHF, associated with AH and stable IHD and stable COPD. By the results of this study there were determined different types of left ventricle geometry: concentric LV hypertrophy (LVH), eccentric LVH, mixed LVH, dilated LVH, dependent on blood pressure level, fibrosic and ischemic myocardial changes,, primary predominant disease – AH, IHD or COPD.

Author Biography

V. A. Potabashniy

SE «Dnipropetrovsk medical academy of Health Ministry of Ukraine»
Department of therapy, cardiology and family medicine
Dzerzhinsky str., 9, Dnipropetrovsk, 49044, Ukraine


Dziak GV. [Effectiveness of ivabradine in pa-tients with cardiorespiratory pathology]. Ukr. Pulmonol. Zh. 2008;3(supl.):55. Russian.

Dolgusheva YA, Zikov KA, Chasova IY. [B-ago-nists different actions in patients with combined car-diovascular pathology and bronchoobstructive diseases]. Practical pulmonology. 2015;2:41-47. Russian.

Koval EA. [CHF in comorbities condition: choice of optimal b-blocker]. Health of Ukraine. 2015; 3(40):19. Russian.

[On approval and implementation of medical and technological documents on standartization of medical care in arterial hypertention: Order N 284 MoH of Ukraine]; 2012. Ukrainian.]

[On approval and implementation of medical and technological documents on standartization of medical care in stable ischemic heart disease: Order N 152 MoH of Ukraine]; 2016. Ukrainian.

[On approval and implementation of medical and technological documents on standartization of medical care in chronic obstructive pulmonary disease: Order N 555 MoH of Ukraine]; 2013. Ukrainian.]

Barnes PJ, Celli BR. Systemic manifestations and comorbidities of COPD. Eur. Respir. J. 2009;33:1165-85.

Campo G, Guastaroba P, Marzocchi A, Santarelli A, Varani E, Vignali L, Sangiorgio P, Tondi S, Serenelli C, De Palma R, Saia F. Impact of COPD on long-term outcome after ST-segment elevation myocardial infar-ction receiving primary percutaneous coronary inter-vention. Chest. 2013;144:750-7.

Campo G, Pavasini R, Biscaglia S, Contoli M, Ceconi C. Overview of the pharmacological challenges facing physicians in the management of patients with concomitant cardiovascular disease and chronic obstruc-tive pulmonary disease. Eur. Heart J. – Cardiovasc. Pharmacother. 2015;1:205-11.

Waheed S, Chaves PHM, Gardin JM, Cao JJ. Car-diovascular and mortality outcomes in the elderly with im¬paired cardiac and pulmonary function: The Cardiovascular Health Study (CHS). J. Am. Heart Assoc. 2015;4:1-10.

Valk MJ, Broekhuizen BD, Mosterd A, Zuithoff NP, Hoes AW, Rutten FH. COPD in patients with stable heart failure in the primary care setting. Intern. J. COPD. 2015;10:1219-24.

van Deursen VM, Urso R, Laroche C, Damman K, Dahlström U, Tavazzi L, Maggioni AP, Voors AA. Co-morbidities in patients with heart failure: an analysis of the European Heart Failure Pilot Survey. Eur. J. Heart Failure. 2014;16:103-11.

Fisher KA. Impact of COPD on the mortality and treatment of patients hospitalized with acute decom¬pen-sated heart failure (The Worcester Heart Failure Study): A Masters Thesis. University of Massachusetts Medical School. - GSBS Dissertations and Theses; 2014. Available from:¬bs_diss/717.

Gaasch WH, Zile MR. Left ventricular structural re¬mo¬deling in health and disease:with special emphasis on volu¬me, mass, and geometry. J.Am.Coll. Cardiol. 2011;58:1733-40.

Global Initiative for chronic obstructive lung di-sease – global strategy for the diagnosis, management and prevention for chronic obstructive pulmonary disease. Updated; 2016.

Guzik TJ, Grodzicki T. “Radical” Link Between Chronic Obstructive Pulmonary Disease and Cardiovas-cular Disease? Hypertension. 2014;63:444-6.

Wakabayashi K, Gonzalez MA, Delhaye C, Ben-Dor I, G.Maluenda G. Impact of chronic obstructive pul-monary disease on acute phase outcome of myocardial infarction. Am. J. Cardiol. 2010;106:305-9.

Donaldson GC, Hurst JR, Smith CJ, Hubbard RB, Wedzicha JA. Increased risk of myocardial infarction and stroke following exacerbation of COPD. Chest. 2010;137:1091-7.

Lahousse L, Niemeijer MN, van den Berg ME. Chronic obstructive pulmonary disease and sudden car-diac death: the Rotterdam study. Eur. Heart J. doi:10.1093/eurheartj/ehv121; 2015.

Lainscak M, Anker SD. Heart failure, chronic ob-structive pulmonary disease, and asthma: numbers, facts, and challenges. ESC Heart Failure. 2015;2:1-5.

Maclay D, MacNee W. Cardiovascular disease in COPD. Chest. 2013;143:798-807.

Feary JR, Rodrigues LC, Smith CJ, Hubbard RB, Gibson JE. Prevalence of major comorbidities in subjects with COPD and incidence of myocardial infarction and stroke: a comprehensive analysis using data from primary care. Thorax. 2010;65:956-62.

Recommendations for cardiac chamber quantifi-cation by echocardiography: an update from the American Society of Echocardiography and the European As¬sociation of Cardiovascular Imaging. J.Am.Soc. Echocar¬diogr. 2015;28:1–39.

Marwick TH, Gillebert TC, Aurigemma G, Chi-rinos J, Derumeaux G, Galderisi M, Gottdiener J, Haluska B, Ofili E, Segers P, Senior R, Tapp RJ, Zamorano JL. Recommendations on the use of echocardiography in adult hypertension: a report from the European Asso-ciation of Cardiovascular Imaging (EACVI) and the American Society of Echocardiography (ASE). Eur. Heart J. - Cardiovasc. Imag. 2015;16:577-605.

Rothnie KJ, Smeeth L, Herrett E. Closing the mortality gap after a myocardial infarction in people with and without chronic obstructive pulmonary disease. Heart. 2015;101:1103-10.

The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Guidelines on myocardial revascularization. Eur. Heart J. 2014;35:2541-619.




How to Cite

Potabashniy VA. Novel approach for identification of left ventricle geometry in patients with chronic heart failure, AH and IHD in combination with COPD. Med. perspekt. [Internet]. 2016May31 [cited 2024Jun.13];21(2):39-46. Available from: